Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells

Cell Cycle

Volumn 3, Issue 8, 2004, Pages 1003-1005

  Voeller, Donna ^a   Rahman, Lambratu ^a   Zajac Kaye, Maria ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Molecular Therapeutic Program   (United States)

Author keywords

Apoptosis; Cellular transformation; E2F 1; Thymidylate synthase

Indexed keywords

BIOLOGICAL MARKER; DNA; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; APOPTOSIS; CANCER; CANCER PREVENTION; CANCER THERAPY; CELL CYCLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; COLORECTAL CANCER; DNA REPAIR; DNA SYNTHESIS; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MAMMAL CELL; NONHUMAN; REVIEW;

EID: 13944259353     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.8.1064     Document Type: Review

References (21)

1. Rahman L, Voeller D, Rahman M, Lipkowitz S, Allegra C, Barrett JC, Kaye FJ, Zajac-Kaye M. Thymidylate synthase as an oncogene: A novel role for an essential DNA synthesis enzyme. Cancer Cell 2004; 5:341-51.
2. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995; 55:1407-12,
3. Pestalozzi BC, Peterson HF, Gelber RD, Goldhirsch A, Gusterson BA, Trihia H, Lindtner J, Cortes-Funes H, Simmoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Allegra CJ, Johnston PG. Prognostic importance of thymidylate synthase expression in early breast cancer. J Clin Oncol 1997; 15:1923-31.
4. Suzuki M, Tsukagoshi S, Saga Y, Ohwada M, Saro I. Enhanced expression of thymidylate synthase may be of prognostic importance in advanced cervical cancer. Oncology 1999; 57:50-4.
5. Leichman CG. Predictive and prognostic markers in gastrointestinal cancers. Curr Opin Oncol 2001; 13:291-9.
6. Nomura T, Nakagawa M, Fujita Y, Hanada T, Mimata H, Nomura Y. Clinical significance of thymidylate synthase expression in bladder cancer. Int J Urol 2002; 9:368-76.
7. Mizutani Y, Wada H, Yoshida O, Fukushima M, Nonomura M, Nakao M, Miki T. Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res 2003; 9:1453-60.
8. Chu E, Koeller DM. Casey JL, Drake JC, Chabner BA, Elwood PC, Zinn S, Allegra CJ. Auto regulation of human thymidylate synthase messenger RNA Translation by thymidylate synthase. Proc Natl Acad Sci USA 1991; 88:8977-81.
9. Chu E, Takechi T, Jones KL, Voeller DM, Copur SM, Maley GF, Maley F, Segal S, Allegra CJ. Thymidylare synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol Cell Biol 1995; 15:179-85.
10. Chu E, Copur SM, Ju J, Chen TM, Khleif S, Voeller DM, Mizunuma N, Patel M, Maley GF, Maley F, Allegra CJ. Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex. Mol Cell Biol 1999; 19:1582-94.
11. Bertino JR, Banerjee D. Thymidylare synthase as an oncogene? Cancer Cell 2004; 5:301-2.
12. Kastanos EK, Zajac-Kaye M, Dennis PA, Allegra CJ. Downregulation of p21/WAF1 expression by thymidylate synthase. Biochem Biophys Res Commun 2001; 285:195-200.
13. Bradley MO, Sharkey NA. Mutagenicity of rhymidine to cultured Chinese hamster cells. Nature 1978; 274:607-8.
14. Meuth M. Sensitivity of a mutator gene in Chinese hamster ovary cell to deoxynucleoside triphosphate pool alterations. Mol Cell Biol 1981; 1:652-60.
15. Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res 1989; 181:305-16.
16. Angus SP, Wheeler LJ, Ranmal SA, Zhang X, Markey MP, Mathews CK, Knudsen ES. Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication. J Biol Chem 2002; 277:44376-84.
17. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 1998; 8:28-35.
18. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12:2245-62.
19. Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000; 14:2393-409.
20. Chu E, Allegra CJ. Mechanisms of clinical resistance to 5-fluorouracil chemotherapy. Cancer Treat Res 1996; 87:175-95.
21. Wang TL, Diaz LA Jr, Romans K, Bardelli A, Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih IeM, Iacobuzio-Donahue C, Kinder KW, Vogelsrein B, Lengauer C, Velculescu VE. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci USA 2004; 101:3089-94.